[{"bbox": [91, 100, 367, 132], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [636, 170, 1014, 203], "category": "Section-header", "text": "Q- LINE BIOTECH LIMITED"}, {"bbox": [1420, 203, 1557, 232], "category": "Section-header", "text": "Annexure I"}, {"bbox": [348, 234, 1301, 265], "category": "Section-header", "text": "RESTATED CONSOLIDATED STATEMENT OF ASSETS AND LIABILITIES"}, {"bbox": [1285, 267, 1557, 297], "category": "Text", "text": "(Amount in Rs. Lakhs)"}, {"bbox": [91, 295, 1557, 2094], "category": "Table", "text": "<table><thead><tr><th rowspan=\"2\">PARTICULARS</th><th rowspan=\"2\"></th><th rowspan=\"2\">Annexure No</th><th colspan=\"3\">As at</th></tr><tr><th>31-03-2025</th><th>31-03-2024</th><th>31-03-2023</th></tr></thead><tbody><tr><td>A) EQUITY AND LIABILITIES</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>1. Shareholders' Funds</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>(a) Share Capital</td><td rowspan=\"3\">A</td><td></td><td>157.50</td><td>157.50</td><td>157.50</td></tr><tr><td>(b) Reserves & Surplus</td><td></td><td>18,837.03</td><td>16,023.94</td><td>12,579.02</td></tr><tr><td></td><td></td><td><strong>18,994.53</strong></td><td><strong>16,181.44</strong></td><td><strong>12,736.52</strong></td></tr><tr><td>2. Minority Interest</td><td></td><td></td><td>-</td><td>-</td><td>-</td></tr><tr><td>3. Non Current Liabilities</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>(a) Long Term Borrowings</td><td>B, B(A) and B(B)</td><td></td><td>8,241.18</td><td>3,509.30</td><td>1,430.69</td></tr><tr><td>(b) Deferred Tax Liabilities (Net)</td><td>C</td><td></td><td>-</td><td>-</td><td>-</td></tr><tr><td>(c) Other Long Term Liabilities</td><td>D</td><td></td><td>136.75</td><td>20.29</td><td>10.00</td></tr><tr><td>(d) Long Term Provisions</td><td>D1</td><td></td><td>261.82</td><td>185.83</td><td>165.81</td></tr><tr><td></td><td></td><td></td><td><strong>8,639.75</strong></td><td><strong>3,715.41</strong></td><td><strong>1,606.50</strong></td></tr><tr><td>4. Current Liabilities</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>(a) Short Term Borrowings</td><td>B, B(A) and B(B)</td><td></td><td>8,253.80</td><td>6,181.70</td><td>5,934.15</td></tr><tr><td>(b) Trade Payables</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>(i) total outstanding dues of micro enterprises and small enterprises; and</td><td rowspan=\"2\">E</td><td></td><td>214.32</td><td>168.75</td><td>28.07</td></tr><tr><td>(ii) total outstanding dues of other than micro enterprises and small enterprises.</td><td></td><td>5,348.17</td><td>5,755.01</td><td>3,942.55</td></tr><tr><td>(c) Other Current Liabilities</td><td rowspan=\"3\">F</td><td></td><td>2,498.35</td><td>1,664.27</td><td>612.69</td></tr><tr><td>(d) Short Term Provisions</td><td></td><td>1,599.67</td><td>258.01</td><td>297.48</td></tr><tr><td></td><td></td><td><strong>17,914.32</strong></td><td><strong>14,027.75</strong></td><td><strong>10,814.94</strong></td></tr><tr><td>Total</td><td></td><td></td><td><strong>45,548.59</strong></td><td><strong>33,924.60</strong></td><td><strong>25,157.96</strong></td></tr><tr><td>B) ASSETS</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>1. Non Current Assets</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>(a) Property, Plant & Equipment and Intangible Assets</td><td rowspan=\"5\">G</td><td></td><td></td><td></td><td></td></tr><tr><td>vi) Property, Plant & Equipment</td><td></td><td>5,347.24</td><td>5,487.04</td><td>2,272.31</td></tr><tr><td>vii) Intangible Assets</td><td></td><td>1,989.32</td><td>505.08</td><td>8.07</td></tr><tr><td>viii) Goodwill on Consolidation</td><td></td><td>26.86</td><td>-</td><td>-</td></tr><tr><td>ix) Capital Work in Progress</td><td></td><td>5,903.11</td><td>1,917.21</td><td>1,173.73</td></tr><tr><td>x) Intangible Assets Under development</td><td></td><td>352.30</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td><strong>13,618.83</strong></td><td><strong>7,909.33</strong></td><td><strong>3,454.12</strong></td></tr><tr><td>(b) Non-Current Investment</td><td>H</td><td></td><td>1,794.91</td><td>2,851.14</td><td>1,570.38</td></tr><tr><td>(c) Deferred Tax Assets (Net)</td><td>C</td><td></td><td>98.09</td><td>57.78</td><td>70.72</td></tr><tr><td>(d) Long Term Loans and Advances</td><td>I</td><td></td><td>158.42</td><td>889.02</td><td>1,000.34</td></tr><tr><td>(e) Other Non Current Assets</td><td>J</td><td></td><td>3,414.52</td><td>2,364.18</td><td>1,451.36</td></tr><tr><td></td><td></td><td></td><td><strong>5,465.93</strong></td><td><strong>6,162.12</strong></td><td><strong>4,092.80</strong></td></tr><tr><td>2. Current Assets</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>(a) Current Investments</td><td></td><td></td><td>-</td><td>-</td><td>-</td></tr><tr><td>(b) Inventories</td><td>K</td><td></td><td>9,021.34</td><td>10,524.10</td><td>4,359.44</td></tr><tr><td>(c) Trade Receivables</td><td>L</td><td></td><td>8,260.25</td><td>2,644.36</td><td>3,305.76</td></tr><tr><td>(d) Cash and Bank Balances</td><td>M</td><td></td><td>4,702.60</td><td>2,995.59</td><td>9,001.92</td></tr><tr><td>(e) Short-Term Loans and Advances</td><td>N</td><td></td><td>3,258.04</td><td>3,673.25</td><td>934.33</td></tr><tr><td>(f) Other Current Assets</td><td>N1</td><td></td><td>1,221.59</td><td>15.87</td><td>9.59</td></tr><tr><td></td><td></td><td></td><td><strong>26,463.83</strong></td><td><strong>19,853.15</strong></td><td><strong>17,611.04</strong></td></tr><tr><td>Total</td><td></td><td></td><td><strong>45,548.59</strong></td><td><strong>33,924.60</strong></td><td><strong>25,157.96</strong></td></tr></tbody></table>"}, {"bbox": [803, 2169, 848, 2197], "category": "Page-footer", "text": "182"}]